Similar articles

• [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].

  Radu H, Keresztes L, Stenzel K. Radu H, et al. Minerva Med. 1968 Dec 12;59(99):5524-9. Minerva Med. 1968. PMID: 5718841 Italian. No abstract available.
• [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].

  Esaki K, Tokoro T, Yamamoto K, Kato T, Asano B. Esaki K, et al. Iryo. 1969 Oct;23(10):1306-11. Iryo. 1969. PMID: 5364982 Japanese. No abstract available.
• Biochemical aspects of genetically determined progressive muscular dystrophies.

  Luca N, Haţegan D. Luca N, et al. Rev Roum Neurol. 1973;10(6):531-7. Rev Roum Neurol. 1973. PMID: 4771091 No abstract available.
• [Biochemistry of myopathies].

  Heyck H, Laudahn G. Heyck H, et al. Hippokrates. 1967 Dec 15;38(23):909-22. Hippokrates. 1967. PMID: 4891060 Review. German. No abstract available.
• [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].

  Adami Lami Conti C, Calandi C, Nistri R, Aulisi A, Bucciolini MG, Vannelli G, Ragazzini F. Adami Lami Conti C, et al. Minerva Pediatr. 1981 May 15;33(9):385-412. Minerva Pediatr. 1981. PMID: 7019663 Review. Italian. No abstract available.